Grace Bosma
Title | Research Scientist |
---|
Institution | University of Colorado Denver - Anschutz Medical Campus |
---|
Department | CSPH-Bio Info General Ops |
---|
|
|
|
Bibliographic
-
Santos J, Abbott D, Bosma G, Kent A, Schwartz M, McMahon CM, Gutman J, Pollyea DA, Amaya ML. Comparison of treatment-related and de novo CCUS: a retrospective analysis from two centers. Leuk Lymphoma. 2025 Mar 13; 1-3. PMID: 40080662.
-
Thibodeau P, Bosma GN, Hochheimer CJ, Syed A, Dieujuste N, Mann A, Fainstad T. The Moderating Effects of Moral Injury and Discrimination Trauma on Women Physician Trainees' Well-Being. J Gen Intern Med. 2025 Feb 25. PMID: 40000525.
-
Ambroggio L, Florin TA, Williamson K, Bosma G, Wagner BD, Yeomans L, Kim JH, Sucharew H, Macaluso M, Ruddy RM, Stringer KA, Shah SS. Urine Metabolites of Suspected Community-Acquired Pneumonia. J Infect Dis. 2025 Feb 12. PMID: 39938055.
-
Gil KB, Abbott D, Amaya ML, Schwartz M, Gutman JA, Kent A, Bosma G, Pollyea DA, McMahon CM. Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia. Leuk Lymphoma. 2024 Dec; 65(14):2228-2230. PMID: 39229898.
-
Kent A, Gil KB, Jones MK, Linden B, Purev E, Haverkos B, Schwartz M, McMahon C, Amaya M, Smith CA, Bosma G, Abbott D, Rabinovitch R, Milgrom SA, Pollyea DA, Gutman JA. Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis. Transplant Cell Ther. 2025 Apr; 31(4):267.e1-267.e11. PMID: 39154914.
-
Hlavin D, Bosma GN, Bolt MA, Sammel MD, Seyller N, Varty M. Evaluating the Accuracy of Off-Label Placement of Pulse Oximetry Sensors in Comparison to On-Label Placement in the Adult Cardiac Intensive Care Unit Patient Population. Dimens Crit Care Nurs. 2024 Jul-Aug 01; 43(4):176-183. PMID: 38787772.
-
Winters AC, Minhajuddin M, Stevens BM, Major A, Bosma G, Abbott D, Miltgen N, Yuan J, Treece AL, Siegele BJ, Ewalt MD, Gutman JA, Jordan CT, Pollyea DA. Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine. Haematologica. 2024 06 01; 109(6):1766-1778. PMID: 38105738.
-
Fang J, Bosma G, Aisner D, McMahon C, Amaya M, Schwartz M, Kaiser J, Abbott D, Pan Z, Schowinsky J, Pang C, Gutman JA, Pollyea DA. White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia. Leuk Lymphoma. 2024 Jun; 65(6):800-807. PMID: 38814858.
-
Hochheimer CJ, Bosma GN, Gunn-Sandell L, Sammel MD. Reproducible research practices: A tool for effective and efficient leadership in collaborative statistics. Stat. 2024; 13(1). PMID: 39238941.
-
Perez de Acha O, Reiman L, Jayabalan DS, Walker ZJ, Bosma G, Keller AL, Parzych SE, Abbott D, Idler BM, Ribadeneyra D, Niesvizky R, Forsberg PA, Mark TM, Sherbenou DW. CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies. Blood Adv. 2023 11 14; 7(21):6430-6440. PMID: 37648670.
-
Sivesind TE, Oganesyan A, Bosma G, Hochheimer C, Schilling LM, Dellavalle R. Prescribing Patterns of Dupilumab for Atopic Dermatitis in Adults: Retrospective, Observational Cohort Study. JMIR Dermatol. 2023 Aug 30; 6:e41194. PMID: 37647114.
-
Adelman MJ, Sivesind TE, Weber I, Bosma G, Hochheimer C, Karimkhani C, Schilling LM, Barbieri JS, Dellavalle RP. Prescribing Patterns of Oral Antibiotics and Isotretinoin for Acne in a Colorado Hospital System: Retrospective Cohort Study. JMIR Dermatol. 2023 Aug 21; 6:e42883. PMID: 37603402.
-
Kent A, Schwartz M, McMahon C, Amaya M, Smith CA, Tobin J, Marciano K, Rezac R, Bosma G, Pollyea DA, Gutman JA. Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse. Bone Marrow Transplant. 2023 08; 58(8):849-854. PMID: 37185614.
-
Winters AC, Bosma G, Abbott D, Minhajuddin M, Jordan C, Pollyea DA, Gutman JA. Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax?+?Azacitidine Versus Intensive Chemotherapy. Transplant Cell Ther. 2022 10; 28(10):694.e1-694.e9. PMID: 35902048.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2022 | 1 | 2023 | 4 | 2024 | 6 | 2025 | 3 |
To return to the timeline, click here.
|
Bosma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|